Invesaro

Stocks OGN DCF valuation

DCF valuation

What is Organon & Co. worth?

With the base-case assumptions below, a discounted cash flow model on Organon & Co.'s reported free cash flow gives -$1.82 per share. The share price was $13.73 on September 25, 2026, 855% below that value.

Inputs from the filings

Free cash flow, fiscal 2025
$538M
Average free cash flow, last 5 years
$896M
Cash
$1.13B
balance sheet of June 30, 2026
Debt
$8.55B
balance sheet of June 30, 2026
Diluted shares, fiscal 2025
260,764,000
Revenue growth per year, last 4 years
-1.2%

Three sets of assumptions

CaseGrowth yrs 1-5Growth yrs 6-10After year 10Discount rateValue per shareValue vs price
Bear-6.0%-2.0%2.0%10.0%-$11.76-186%
Base-1.0%1.0%2.5%9.0%-$1.82-113%
Bull4.0%3.5%3.0%8.0%$16.74+22%

Sensitivity: base case value per share

Discount rate down the side, growth after year 10 across the top. Everything else as in the base case.

1.5%2.0%2.5%3.0%3.5%
7.0%$5.01$7.05$9.54$12.66$16.66
8.0%-$0.05$1.27$2.83$4.71$7.00
9.0%-$3.77-$2.86-$1.82-$0.60$0.84
10.0%-$6.61-$5.97-$5.24-$4.41-$3.45
11.0%-$8.86-$8.39-$7.86-$7.27-$6.60

Where the presets come from

Base: years 1 to 5 grow at Organon & Co.'s revenue growth rate over the last 4 fiscal years (-1.2% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.

Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.

Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.

This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.

Adjust the assumptions

Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.

Adjust the assumptions

Organon & Co. company page